Symbols

Symbols

BNTC

Benitec Biopharma·NASDAQ

--

--(--)

--

--(--)

BNTC fundamentals

BNTC Q3 2025 Earnings

Benitec Biopharma (BNTC) released its earnings on May 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.24 (YoY +85.37%), beat estimates.

Revenue / YoY

0

--

EPS / YoY

-0.24

+85.37%

Report date

May 14, 2025

EPS

Actual						-10.54	-10.03	-6.8	-10.54	-7.99	-3.4	-2.72	-0.01	-2.76	-2.64	-1.64	1.04	-0.48	-0.33	-0.24
Forecast			-12.75	-14.45	-15.81			-7.48	-4.76	-3.145	-1.87	-3.4	-3.23	-0.51	-0.39	-0.78	-0.4875	-0.55	-0.7757	-0.3483
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+9.09%	-121.43%	-154.05%	-81.82%	+20.00%	+99.69%	-441.18%	-576.92%	-110.26%	+313.33%	+12.73%	+57.46%	+31.09%

Revenue

Actual	--	--	--	--	--	0	25.00K	48.00K	0	0	14.00K	54.00K	15.00K	0	0	0	0	0	0	0
Forecast	--	--	35.00K	5.00K	5.00K	--	--	0	0	9.50K	0	0	0	0	0	0	0	0	0	0
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-100.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Earnings Call

You can ask Aime

What is the revenue and EPS growth rate for Benitec Biopharma year over year?

Did Benitec Biopharma beat or miss consensus estimates last quarter?

What is Benitec Biopharma's latest dividend and current dividend yield?

What were the key takeaways from Benitec Biopharma's earnings call?

What were the key takeaways from Benitec Biopharma’s earnings call?

What factors drove the changes in Benitec Biopharma's revenue and profit?

What guidance did Benitec Biopharma's management provide for the next earnings period?

What is Benitec Biopharma's gross profit margin?